MAIA Biotechnology Inc (MAIA)
3.74
-0.07
(-1.84%)
USD |
NYAM |
May 24, 16:00
3.73
-0.01
(-0.27%)
After-Hours: 20:00
MAIA Biotechnology Research and Development Expense (Annual): 11.11M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.11M |
| December 31, 2022 | 8.933M |
| Date | Value |
|---|---|
| December 31, 2021 | 3.453M |
| December 31, 2020 | 1.412M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
1.412M
Minimum
2020
11.11M
Maximum
2023
6.228M
Average
6.193M
Median
Research and Development Expense (Annual) Benchmarks
| Cyclacel Pharmaceuticals Inc | 19.16M |
| Avid Bioservices Inc | -- |
| Oragenics Inc | 15.49M |
| NeuBase Therapeutics Inc | 21.45M |
| Viking Therapeutics Inc | 63.81M |